Frequently asked questions
The aim of the glossary is to establish a common language and to aid understanding of key terms that will feature in project outputs. The glossary itself, presented in the document, may be updated during the Trials@Home project so that important new terms can be added, obsolete terms removed, or existing terms updated to significant new insights. This approach has been chosen to reflect the fast-changing remote decentralised clinical trial landscape.
April 2020 – Identifying existing RCDT solutions
In this current stage we are exploring and mapping existing RDCT technologies across-the-board in any stage of the RCT.
To support our research we provide the opportunity for companies to submit their technologies through a Request for Information.